Plus Therapeutics Inc
Plus Therapeutics Inc Stock, NASDAQ:PSTV
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. It focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Austin, TX.